Blood Cancer Journal (Nov 2024)

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

  • Rossana Di Staso,
  • Beatrice Casadei,
  • Frederick L. Locke,
  • Michael Jain,
  • Timothy J. Voorhees,
  • Adam S. Kittai,
  • Mariana Bastos-Oreiro,
  • Antonio Gutiérrez,
  • Alejandro Martin Garcia-Sancho,
  • Maria Jose Terol,
  • Monica Mead,
  • Michael J. Maranzano,
  • Gloria Iacoboni,
  • Pere Barba,
  • Mi Kwon,
  • Rebeca Bailen,
  • Juan Luis Reguera-Ortega,
  • Agrima Mian,
  • Brian Hill,
  • Emmanuel Bachy,
  • Franck Morschhauser,
  • Roch Houot,
  • Catherine Thieblemont,
  • Steven Le Gouill,
  • Riccardo Masetti,
  • Davide Gori,
  • Alessandro Broccoli,
  • Pier Luigi Zinzani,
  • Lisa Argnani

DOI
https://doi.org/10.1038/s41408-024-01183-8
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 5

Abstract

Read online

No abstracts available.